ValiRx Share Price | |
---|---|
Price | 3.35 |
Bid | 3.30 |
Ask | 3.40 |
Change | 0.05 (1.52%) |
Volume | 164,059 |
Open | 3.30 |
High | 3.35 |
Low | 3.30 |
Prev. Close | 3.30 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 132.35m |
Market Capitalisation | £4.43m |
Market Size | 15,000 |
52 Week High | 14.75 |
52 Week High Date | 03-Nov-2023 |
52 Week Low | 3.25 |
52 Week Low Date | 25-Apr-2024 |
# Trades | 7 |
---|---|
Vol. Sold | 70,000 |
Sold Value | £2.33k |
Vol. Bought | 94,059 |
Bought Value | £3.18k |
PE Ratio | -1.094771 |
Earnings | -3.06 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 16:25:50 | 3.35 | 22,500 | Buy* | 3.30 | 3.40 | 753.75 | O Ordinary |
26-Apr-24 | 16:13:12 | 3.325 | 70,000 | Sell* | 3.30 | 3.40 | 2,328 | O Ordinary |
26-Apr-24 | 16:00:39 | 3.40 | 45 | Buy* | 3.30 | 3.40 | 1.53 | O Ordinary |
26-Apr-24 | 15:53:08 | 3.40 | 12,500 | Buy* | 3.30 | 3.40 | 425.00 | O Ordinary |
26-Apr-24 | 15:18:04 | 3.39 | 56,047 | Buy* | 3.20 | 3.40 | 1,900 | O Ordinary |
26-Apr-24 | 15:14:39 | 3.40 | 2,941 | Buy* | 3.20 | 3.40 | 99.99 | O Ordinary |
26-Apr-24 | 14:21:07 | 3.40 | 26 | Buy* | 3.20 | 3.40 | 0.88 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Jul-22 | 07-Jul-22 | Placing | Gerald Desler held the position of CFO at the time of this trade.Gerald Desler | 10.00 | GBX | 25,000 | 128,668 |
07-Jul-22 | 07-Jul-22 | Placing | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 10.00 | GBX | 100,000 | 372,333 |
07-Jul-22 | 07-Jul-22 | Placing | Martin Lampshire held the position of Non-Executive Director at the time of this trade.Martin Lampshire | 10.00 | GBX | 100,000 | 144,000 |
07-Jul-22 | 07-Jul-22 | Placing | Suzanne Dilly held the position of CEO at the time of this trade.Suzanne Dilly | 10.00 | GBX | 100,000 | 416,668 |
18-Feb-21 | 17-Feb-21 | Buy | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 22.25 | GBX | 22,000 | 272,333 |
Click here to read more about our shareholder information - providing intellectual, corporate and financial support in the early stages of drug development.